Bioceltix S.A. (WSE:BCX)
92.90
-1.90 (-2.00%)
At close: Dec 5, 2025
Bioceltix Balance Sheet
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Cash & Equivalents | 23.95 | 33.63 | 9.31 | 4.12 | 6.05 |
| Cash & Short-Term Investments | 23.95 | 33.63 | 9.31 | 4.12 | 6.05 |
| Cash Growth | -37.30% | 261.24% | 125.98% | -31.96% | - |
| Accounts Receivable | - | 0 | 0 | 0 | - |
| Other Receivables | 2.25 | 4.98 | 1.88 | 0.23 | 0.44 |
| Receivables | 2.25 | 4.98 | 1.88 | 0.23 | 0.44 |
| Inventory | 0.03 | 0.01 | 0.01 | - | - |
| Prepaid Expenses | - | 0.02 | 0.01 | 0.01 | 0.01 |
| Other Current Assets | - | 0.77 | 0 | 1.67 | 0.01 |
| Total Current Assets | 26.23 | 39.42 | 11.21 | 6.02 | 6.51 |
| Property, Plant & Equipment | 3.53 | 2.37 | 1.48 | 1.46 | 1.53 |
| Long-Term Deferred Tax Assets | 0.04 | 0.03 | 0.04 | 0.03 | 0.02 |
| Other Long-Term Assets | 0.37 | 0.03 | - | 0.14 | 0.14 |
| Total Assets | 30.17 | 41.85 | 12.74 | 7.65 | 8.2 |
| Accounts Payable | - | 1.49 | 1.21 | 0.96 | 0.29 |
| Accrued Expenses | 0.35 | 0.56 | 0.44 | 0.34 | 0.19 |
| Current Portion of Leases | - | 0.67 | 0.1 | 0.12 | 0.38 |
| Current Income Taxes Payable | - | 0.46 | 0.36 | 0.27 | 0.12 |
| Current Unearned Revenue | - | 0.01 | 0.03 | 0.56 | 0.93 |
| Total Current Liabilities | 2.97 | 3.2 | 2.14 | 2.25 | 1.91 |
| Long-Term Leases | 0.11 | 0.15 | 0.08 | 0.18 | 0.15 |
| Long-Term Unearned Revenue | - | - | - | 0.03 | 0.06 |
| Pension & Post-Retirement Benefits | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 |
| Long-Term Deferred Tax Liabilities | 0.06 | 0.07 | 0.04 | 0.04 | 0.07 |
| Total Liabilities | 3.16 | 3.44 | 2.27 | 2.5 | 2.2 |
| Common Stock | 0.49 | 0.49 | 0.41 | 0.34 | 0.33 |
| Additional Paid-In Capital | 37.92 | 52.82 | 23.8 | 14.44 | 15.14 |
| Retained Earnings | -11.41 | -14.9 | -13.74 | -13.99 | -9.47 |
| Comprehensive Income & Other | - | - | - | 4.36 | - |
| Shareholders' Equity | 27 | 38.42 | 10.47 | 5.15 | 6 |
| Total Liabilities & Equity | 30.17 | 41.85 | 12.74 | 7.65 | 8.2 |
| Total Debt | 0.11 | 0.82 | 0.18 | 0.29 | 0.53 |
| Net Cash (Debt) | 23.84 | 32.81 | 9.14 | 3.83 | 5.52 |
| Net Cash Growth | -36.01% | 259.15% | 138.76% | -30.74% | - |
| Net Cash Per Share | - | 7.23 | 2.33 | 1.15 | 1.75 |
| Filing Date Shares Outstanding | - | 4.92 | 4.13 | 3.98 | 3.29 |
| Total Common Shares Outstanding | - | 4.92 | 4.13 | 3.43 | 3.29 |
| Working Capital | 23.26 | 36.23 | 9.07 | 3.78 | 4.61 |
| Book Value Per Share | - | 7.80 | 2.53 | 1.50 | 1.82 |
| Tangible Book Value | 27 | 38.42 | 10.47 | 5.15 | 6 |
| Tangible Book Value Per Share | - | 7.80 | 2.53 | 1.50 | 1.82 |
| Buildings | - | 0.33 | 0.33 | 0.33 | 0.33 |
| Machinery | - | 0.3 | 0.27 | 0.24 | 0.25 |
| Construction In Progress | - | 0.1 | - | - | - |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.